CN106551219A - 一种具有解酒功能的蜂蜜饮料及其制备方法 - Google Patents
一种具有解酒功能的蜂蜜饮料及其制备方法 Download PDFInfo
- Publication number
- CN106551219A CN106551219A CN201510585984.9A CN201510585984A CN106551219A CN 106551219 A CN106551219 A CN 106551219A CN 201510585984 A CN201510585984 A CN 201510585984A CN 106551219 A CN106551219 A CN 106551219A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- mel
- aqueous solution
- preparation
- wind turbine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 229940088594 vitamin Drugs 0.000 claims abstract description 28
- 229930003231 vitamin Natural products 0.000 claims abstract description 28
- 235000013343 vitamin Nutrition 0.000 claims abstract description 28
- 239000011782 vitamin Substances 0.000 claims abstract description 28
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 27
- 239000007864 aqueous solution Substances 0.000 claims abstract description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 16
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 16
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 16
- 235000005822 corn Nutrition 0.000 claims abstract description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 14
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 14
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 8
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 8
- 229960000304 folic acid Drugs 0.000 claims abstract description 8
- 235000019152 folic acid Nutrition 0.000 claims abstract description 8
- 239000011724 folic acid Substances 0.000 claims abstract description 8
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 8
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 8
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 8
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 7
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 7
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 7
- 229960002685 biotin Drugs 0.000 claims abstract description 7
- 235000020958 biotin Nutrition 0.000 claims abstract description 7
- 239000011616 biotin Substances 0.000 claims abstract description 7
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 7
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 7
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960002477 riboflavin Drugs 0.000 claims abstract description 7
- 238000012859 sterile filling Methods 0.000 claims abstract description 7
- 229960003495 thiamine Drugs 0.000 claims abstract description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 7
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 7
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 7
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 7
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 7
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 7
- 239000011718 vitamin C Substances 0.000 claims abstract description 7
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 7
- 240000008042 Zea mays Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims 2
- 235000019156 vitamin B Nutrition 0.000 abstract description 7
- 239000011720 vitamin B Substances 0.000 abstract description 7
- 229930003270 Vitamin B Natural products 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 239000002932 luster Substances 0.000 abstract description 3
- 235000019614 sour taste Nutrition 0.000 abstract description 3
- 235000019605 sweet taste sensations Nutrition 0.000 abstract description 3
- 241000209149 Zea Species 0.000 abstract 2
- 238000003756 stirring Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- 230000006870 function Effects 0.000 description 14
- 230000004060 metabolic process Effects 0.000 description 8
- 239000005515 coenzyme Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 101710088194 Dehydrogenase Proteins 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000010579 first pass effect Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 101710086426 Myotoxin Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000006860 carbon metabolism Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公布了一种具有解酒功能的蜂蜜饮料及其制备方法。本发明以蜂蜜、恒顺香醋、玉米肽、B族维生素和维生素C为原料。先将维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、叶酸、生物素、维生素C按一定的质量比，充分溶解定容至100mL得到维生素水溶液，再与蜂蜜、恒顺香醋、玉米肽以一定的质量比混合，搅拌均匀，经过120℃，10秒灭菌，无菌灌装得到具解酒功能的蜂蜜饮料。本发明产品具有良好的色泽和风味、酸甜可口，解酒功效良好。
Description
技术领域
本发明涉及一种食品制造技术领域，特别是一种具有解酒功能的蜂蜜饮料及其制备方法。
背景技术
醉酒是因为饮酒过量，乙醇在体内的吸收率大于氧化代谢率，较多乙醇经血液循环进入人体，导致中枢神经系统障碍；乙醇代谢中产生大量乙醛，乙醛作为一种强力肌肉毒素，在组织和脏器内大量积累，损伤脏器；酒精代谢中产生大量自由基，刺激神经系统，导致自律神经平衡失调，引起心脏加速和血液中的水分和电解质平衡失调，对肝脏等多个器官造成损伤。最终造成头痛、晕眩、局部皮肤过敏，肠胃不适等酒后症状。
解酒和缓解酒后不适症状主要从加强乙醇的首过代谢、抑制乙醇的肠胃吸收，增强代谢和增强机体清除自由基能力三个方面考虑。
蜂蜜中约含有60%~80%的葡萄糖和果糖，易消化吸收、保证能量供给、抗疲劳，并且果糖能促进酒精分解吸收，减缓头痛症状。此外还含有蛋白质、多肽、矿物质、酶类、有机酸和维生素等，营养丰富。可提高人体免疫力、抗肿瘤，调节心血管系统，刺激肝组织再生、保护肝脏。
恒顺香醋主要成分是醋酸，此外还有有机酸、糖类、酯类以及各种氨基酸、多肽、蛋白质、矿物质等微量成分。醋酸等有机酸可促进糖代谢，可促进人体三羧酸循环顺利进行。有研究表明，恒顺香醋具有降血压、降血脂、增强肾功能、清除自由基的功效，可抗菌、利尿、保肝。
玉米肽可显著提高血清中的丙氨酸及亮氨酸，有助于产生稳定的辅酶NAD+，而人体内酒精代谢的重要酶乙醇脱氢酶（ADH）是以NAD+为辅酶的，ADH的活性影响乙醇在肠胃的首过代谢，从而抑制血液中乙醇的升高。
维生素B族，包括维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、叶酸、生物素等，是维持人体正常机能与代谢不可或缺的水溶性维生素，B族维生素全是辅酶，参与能量代谢，可以解除酒精和尼古丁等毒素，保护肝脏。还可以帮助维持心脏、神经系统功能、维持消化系统及皮肤的健康，能增强体力、滋补强身。B族维生素之间有协同作用，也就是说一次摄取全部B族维生素，要比分别摄取效果更好。细胞活动的增加，对维生素B的需求跟着增加，各种维生素B的作用是相辅相成的。B1：B2：B6按1:1:1比例摄取，协同作用效果更好。而如果机体缺乏维生素B，细胞功能马上降低，可引起代谢障碍。
维生素B1对神经组织和精神状态有良好的影响，维生素B2进入人体磷酸化后可结合蛋白质成为一种调节氧化-还原过程的脱氢酶，脱氢酶是维持组织细胞呼吸的重要物质，缺乏易代谢紊乱。维生素B6是机体内许多重要酶系统的辅酶，帮助脑和免疫系统发挥正常的生理机能，可活化体内很多种酶，也是一种温和的利尿剂。维生素B12的主要生理功能是参与制造骨髓红细胞，防止恶性贫血；防止大脑神经受到破坏。烟酸在体内构成脱氢酶的辅酶，在代谢中起重要作用。泛酸可参与肾上腺、激素的制造及抗体的形成，并协助维生素的利用和能量的转化，可构成辅酶A，是酰基转移酶的辅酶。叶酸的辅酶形式是四氢叶酸，促进体内的一碳代谢。生物素是人体内多种酶的辅酶，参与体内的脂肪酸和碳水化合物的代谢，促进蛋白质的合成，还参与维生素B12、叶酸、泛酸的代谢，促进尿素合成与排泄。
维生素C是一种抗氧化剂，可以保护身体免于自由基的威胁。
目前很多解酒产品采用中草药成分，而中草药一般具有一定的毒副作用。再就是目前大部分解酒产品只是从清热解毒，养肝护肝等方面考虑的，未从醉酒和解酒机理方面全面考虑。
发明内容
本发明的目的是克服现有产品存在的上述不足，从醉酒和解酒机理方面着手开发一种以蜂蜜为原料，配以恒顺香醋、玉米肽、B族维生素和维生素C的具有解酒功能的蜂蜜饮料。本发明原料来源广泛、无毒无害，产品具有良好的色泽和风味、酸甜可口，配方合理、工艺简单，解酒功效良好。
为了达到上述目的，本发明采用的技术方案为，将蜂蜜、恒顺香醋、玉米肽和维生素水溶液混合均匀，经过120℃，10秒灭菌，无菌灌装得到具解酒功能的蜂蜜饮料。
（1）维生素水溶液的制备：
各种维生素按如下配比混合，充分溶解于水中，定容到100mL，为维生素水溶液：
维生素B1 0.025~0.5 g/100mL
维生素B2 0.025~0.5 g/100mL
维生素B6 0.025~0.5 g/100mL
维生素B12 0.0001~0.1 g/100mL
烟酸 0.1~3.0 g/100mL
泛酸 0.07~2.0 g/100mL
叶酸 0.01~0.1 g/100mL
生物素 0.01~0.1 g/100mL
维生素C 0.5~7.0 g/100mL
（2）将恒顺香醋、玉米肽、制备好的维生素水溶液按比例添加到蜂蜜中，搅拌混合均匀，蜂蜜、恒顺香醋、玉米肽和维生素水溶液的质量百分比：
蜂蜜
50%~70%
恒顺香醋
10%~30%
玉米肽
5%~15%
维生素水溶液 10%~20%
（3）将上述制备好的混合液，经过120℃，10秒灭菌，无菌灌装得到具解酒功能的蜂蜜饮料。
本发明具有如下优点：
1. 本发明从醉酒和解酒机理方面着手开发解酒功能的蜂蜜饮料，配方合理、工艺简单，产品解酒功效良好。
2. 本发明采用原料无毒无害，发明产品具有良好的色泽和风味、酸甜可口。
3. 本发明产品食用方便。
具体实施方式
为了达到上述目的，本发明采用的技术方案为，将蜂蜜、恒顺香醋、玉米肽和维生素水溶液混合均匀，经过120℃，10秒灭菌，无菌灌装得到具解酒功能的蜂蜜饮料。
（1）维生素水溶液的制备：
各种维生素按如下配比混合，充分溶解于水中，定容到100mL，为维生素水溶液：
维生素B1 0.1g/100mL
维生素B2 0.1g/100mL
维生素B6 0.1g/100mL
维生素B12 0.0005g/100mL
烟酸 2.0g/100mL
泛酸 1.0g/100mL
叶酸 0.04g/100mL
生物素 0.03g/100mL
维生素C 2.0g/100mL。
（2）将恒顺香醋、玉米肽、制备好的维生素水溶液按比例添加到蜂蜜中，搅拌混合均匀，蜂蜜、恒顺香醋、玉米肽和维生素水溶液的质量百分比：蜂蜜60%，恒顺香醋 20%，玉米肽10%，维生素水溶液10%。混合均匀后经过120℃，10秒灭菌，无菌灌装得到具解酒功能的蜂蜜饮料。
Claims (4)
1.一种蜂蜜解酒饮料的制备方法，该方法包括以下步骤：
（1）维生素水溶液的制备：
各种维生素按如下配比混合，充分溶解于水中，定容到100mL，为维生素水溶液：
维生素B1
0.025~0.5 g/100mL
维生素B2
0.025~0.5 g/100mL
维生素B6
0.025~0.5 g/100mL
维生素B12
0.0001~0.1 g/100mL
烟酸
0.1~3.0 g/100mL
泛酸
0.07~2.0 g/100mL
叶酸
0.01~0.1 g/100mL
生物素
0.01~0.1 g/100mL
维生素C
0.5~7.0 g/100mL
（2）将恒顺香醋、玉米肽、制备好的维生素水溶液按比例添加到蜂蜜中，搅拌混合均匀，蜂蜜、恒顺香醋、玉米肽和维生素水溶液的质量百分比：
蜂蜜
50%~70%
恒顺香醋
10%~30%
玉米肽
5%~15%
维生素水溶液
10%~20%
（3）将上述制备好的混合液，经过120℃，10秒灭菌，无菌灌装得到具解酒功能的蜂蜜饮料。
2.根据权利要求1所述的制备方法，其特征在于，所述步骤（1）维生素水溶液由维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、叶酸、生物素、维生素C按一定质量比混合均匀制得。
3.根据权利要求1所述的制备方法，其特征在于，所述步骤（2）蜂蜜解酒饮料的配料为：蜂蜜、恒顺香醋、玉米肽、维生素水溶液。
4.根据权利要求1所述的制备方法，其特征在于，所述步骤（3）采用120℃，10秒灭菌，无菌灌装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510585984.9A CN106551219A (zh) | 2015-09-16 | 2015-09-16 | 一种具有解酒功能的蜂蜜饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510585984.9A CN106551219A (zh) | 2015-09-16 | 2015-09-16 | 一种具有解酒功能的蜂蜜饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106551219A true CN106551219A (zh) | 2017-04-05 |
Family
ID=58413327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510585984.9A Pending CN106551219A (zh) | 2015-09-16 | 2015-09-16 | 一种具有解酒功能的蜂蜜饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106551219A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115553462A (zh) * | 2021-06-30 | 2023-01-03 | 健茂生物科技股份有限公司 | 解酒复方组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103126026A (zh) * | 2011-11-25 | 2013-06-05 | 沈阳科奇医药技术开发有限公司 | 一种解酒饮料及制备方法 |
| CN103431475A (zh) * | 2013-09-05 | 2013-12-11 | 天津市恒安食品有限公司 | 一种解酒果蔬汁饮料及其制备工艺 |
| CN103815490A (zh) * | 2014-03-10 | 2014-05-28 | 尹海日 | 一种饮酒前后饮用的护肝胃解酒饮品及其制备方法 |
-
2015
- 2015-09-16 CN CN201510585984.9A patent/CN106551219A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103126026A (zh) * | 2011-11-25 | 2013-06-05 | 沈阳科奇医药技术开发有限公司 | 一种解酒饮料及制备方法 |
| CN103431475A (zh) * | 2013-09-05 | 2013-12-11 | 天津市恒安食品有限公司 | 一种解酒果蔬汁饮料及其制备工艺 |
| CN103815490A (zh) * | 2014-03-10 | 2014-05-28 | 尹海日 | 一种饮酒前后饮用的护肝胃解酒饮品及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115553462A (zh) * | 2021-06-30 | 2023-01-03 | 健茂生物科技股份有限公司 | 解酒复方组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104366647B (zh) | 一种增强耐力、缓解疲劳的组合物及其制备方法 | |
| TWI392496B (zh) | 具有治療、預防或改善糖尿病或糖尿病併發症之效果的組成物及含其之飲料 | |
| CN107048122A (zh) | 一种能解酒护肝的枳椇子保健饮料及其制备方法 | |
| CN104666996B (zh) | 提神抗疲劳的中药组合物及其制备方法与应用 | |
| CN104107217A (zh) | 预防或治疗宿醉的组合物 | |
| CN106135891A (zh) | 一种对酒精性肝损伤具有保护功能的保健食品 | |
| CN104522635A (zh) | 一种抗疲劳制剂及其制备方法 | |
| CN105581198B (zh) | 一种醒酒维生素营养强化饮料的配方及生产工艺 | |
| US20140356394A1 (en) | Composition for treatment or prevention of obesity, containing water extracts of fomitella fraxinea | |
| CN106333207A (zh) | 一种含壳寡糖的固体饮料及其制备方法 | |
| CN106563099A (zh) | 一种解酒护肝口服液 | |
| CN1238008C (zh) | 一种促进人体排铅的药品或功能性食品及其制备方法 | |
| JP2020072659A (ja) | 続断およびコイケマ抽出物を有効成分として含む運動能力および筋肉増進用組成物 | |
| CN104432063A (zh) | 一种缓解运动性疲劳的组合物及其制剂 | |
| CN101779816A (zh) | 一种金刺梨速溶冲剂及其制备方法 | |
| CN105920198B (zh) | 一种具有补血功效的细胞破壁微粉及其制备方法 | |
| CN106551219A (zh) | 一种具有解酒功能的蜂蜜饮料及其制备方法 | |
| CN104783031B (zh) | 一种护肝护脑组合物 | |
| CN105767831A (zh) | 一种秋葵固体饮料及其制备方法 | |
| CN103948854A (zh) | 解酒护肝保健品及其制备方法 | |
| CN106923335A (zh) | 一种运动营养的功能组合物及应用 | |
| KR101381277B1 (ko) | 홍삼을 함유하는 고장초 겔 | |
| CN106617069A (zh) | 蓝莓红景天复合口服液及其制作方法 | |
| CN103766500B (zh) | 一种抗疲劳奶片 | |
| JP2011032232A (ja) | 興奮抑制用又は鎮静用組成物及びこれを含む飲食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170405 |